Literature DB >> 15776427

Lysinuric protein intolerance: identification and functional analysis of mutations of the SLC7A7 gene.

Maria Pia Sperandeo1, Patrizia Annunziata, Virginia Ammendola, Valentina Fiorito, Antonio Pepe, Maria Virginia Soldovieri, Maurizio Taglialatela, Generoso Andria, Gianfranco Sebastio.   

Abstract

Lysinuric protein intolerance (LPI) is an inherited hyperdibasic aminoaciduria caused by defective cationic amino acid (CAA) transport at the basolateral membrane of epithelial cells in the intestine and kidney. LPI is relatively common in Finland and a few clusters of patients are known in Italy and Japan. The SLC7A7 gene, mutated in LPI patients, encodes the y+LAT-1 protein which is the light subunit of a heterodimeric CAA transporter. We performed the mutation analysis in seven probands from five unrelated LPI families and identified five novel SLC7A7 mutations (p.M50K, p.T188I, p.R333M, p.Y457X, and c.499+?_629-?). By expression studies in X. laevis oocytes or patient's renal tubular cells, the functional analysis of altogether eight SLC7A7 mutations is here reported. Noteworthy, the p.R333M mutation, caused by a G to T transversion of the last nucleotide at 3' end of exon 7, disrupts a functional splicing motif generating misspliced transcripts. Three of the novel mutations were found in patients originating from Greece and Pakistan thus increasing the list of ethnic backgrounds where LPI mutant alleles are present. This reinforces the view that the rarity of LPI outside Finland might be ascribed to misdiagnosis of this disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15776427     DOI: 10.1002/humu.9323

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  7 in total

Review 1.  Overview of symptoms and treatment for lysinuric protein intolerance.

Authors:  Atsuko Noguchi; Tsutomu Takahashi
Journal:  J Hum Genet       Date:  2019-06-18       Impact factor: 3.172

2.  First reported case of lysinuric protein intolerance (LPI) in Lithuania, confirmed biochemically and by DNA analysis.

Authors:  Loreta Cimbalistiene; Willy Lehnert; Kirsi Huoponen; Vaidutis Kucinskas
Journal:  J Appl Genet       Date:  2007       Impact factor: 3.240

3.  Pregnancy and lactation outcomes in a Turkish patient with lysinuric protein intolerance.

Authors:  Ozlem Unal; Turgay Coşkun; Diclehan Orhan; Ayşegül Tokatl; Ali Dursun; Burcu Hişmi; Ozgür Ozyüncü; Serap Hatice Kalkanoğlu Sivri
Journal:  JIMD Rep       Date:  2013-10-20

Review 4.  Heteromeric Amino Acid Transporters in Brain: from Physiology to Pathology.

Authors:  Ekaitz Errasti-Murugarren; Manuel Palacín
Journal:  Neurochem Res       Date:  2021-02-19       Impact factor: 3.996

5.  In Lysinuric Protein Intolerance system y+L activity is defective in monocytes and in GM-CSF-differentiated macrophages.

Authors:  Amelia Barilli; Bianca Maria Rotoli; Rossana Visigalli; Ovidio Bussolati; Gian C Gazzola; Zamir Kadija; Giuseppe Rodi; Francesca Mariani; Maria Lorena Ruzza; Maurizio Luisetti; Valeria Dall'Asta
Journal:  Orphanet J Rare Dis       Date:  2010-11-26       Impact factor: 4.123

6.  SP-D counteracts GM-CSF-mediated increase of granuloma formation by alveolar macrophages in lysinuric protein intolerance.

Authors:  David N Douda; Nicole Farmakovski; Sharon Dell; Hartmut Grasemann; Nades Palaniyar
Journal:  Orphanet J Rare Dis       Date:  2009-12-23       Impact factor: 4.123

7.  Inducible Slc7a7 Knockout Mouse Model Recapitulates Lysinuric Protein Intolerance Disease.

Authors:  Susanna Bodoy; Fernando Sotillo; Meritxell Espino-Guarch; Maria Pia Sperandeo; Aida Ormazabal; Antonio Zorzano; Gianfranco Sebastio; Rafael Artuch; Manuel Palacín
Journal:  Int J Mol Sci       Date:  2019-10-24       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.